Free Trial

Fulcrum Therapeutics (FULC) Insider Trading & Ownership

→ The A.I. story nobody is telling you (Read ASAP) (From TradeSmith) (Ad)
Free fulc Stock Alerts
$7.28
-0.16 (-2.15%)
(As of 04/24/2024 ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media

Fulcrum Therapeutics (NASDAQ:FULC) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
2.50%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
1
Amount Of
Insider Selling
(Last 12 Months)
$57,935.58
Get FULC Insider Trade Alerts

Want to know when executives and insiders are buying or selling Fulcrum Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

FULC Insider Buying and Selling by Quarter

Ad Traders Agency
top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)
AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.
Click here now for the full details of this stock that’s set to rocket in the AI revolution…

Fulcrum Therapeutics Insider and Congressional Trades History

Export to Excel
Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
3/8/2024Greg TourangeauVPSell4,884$11.72$57,240.48  
5/10/2023Greg TourangeauInsiderSell210$3.31$695.10  
(Data available from 1/1/2013 forward)

FULC Insider Trading Activity - Frequently Asked Questions

Who is on Fulcrum Therapeutics's Insider Roster?

The list of insiders at Fulcrum Therapeutics includes Christopher Morabito, Curtis Gale Oltmans, Greg Tourangeau, James A Geraghty, Peter G Thomson, Ra Capital Management, L.P., Robert J Gould. Learn more on insiders at FULC.

What percentage of Fulcrum Therapeutics stock is owned by insiders?

2.50% of Fulcrum Therapeutics stock is owned by insiders. Learn more on FULC's insider holdings.

Which Fulcrum Therapeutics insiders have been buying company stock?

The following insider purchased FULC shares in the last 24 months: Ra Capital Management, L.P. ($38,695,654.65).

How much insider buying is happening at Fulcrum Therapeutics?

Insiders have purchased a total of 4,372,675 FULC shares in the last 24 months for a total of $38,695,654.65 bought.

Which Fulcrum Therapeutics insiders have been selling company stock?

The following insiders have sold FULC shares in the last 24 months: Greg Tourangeau ($57,935.58), and Robert J Gould ($502,114.65).

How much insider selling is happening at Fulcrum Therapeutics?

Insiders have sold a total of 61,793 Fulcrum Therapeutics shares in the last 24 months for a total of $560,050.23 sold.


More Insider Trading Tools from MarketBeat

Related Companies:
Insider Tracking Tools:
Insider Trading By Country:
Latest Articles:
This page (NASDAQ:FULC) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners
He Is Giving Away Bitcoin
Crypto Swap Profits
Bitcoin Rockets To Record High But Buy THIS Instead
Paradigm Press
top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)
Traders Agency
The #1 Crypto for 2024
InvestorPlace
Emergency: Biden's $20 Trillion Mistake Could Cost YOU!
GoldenCrest Metals
Fed launches fourth dollar overhaul
Stansberry Research
Urgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!
American Alternative
1970’s computer coder issues shocking A.I. warning
TradeSmith